For the Inventor, By the Inventor

Enter inventor name

Tiefenbronn, Germany

Klaus Pfizenmaier

USPTO Granted Patents = 20 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 11)

Average Co-Inventor Count = 4.4

ph-index = 4

Forward Citations = 51(Granted Patents)

Company Filing History:

Universitãt Stuttgart

Oncomatryx Biopharma, S.l.

Universitaet Stuttgart

6. 1 out of 4,814

Fraunhofer-gesellschaft Zur Foerderung Der Angewandten Forschung E.v.

Universitat of Stuttgart

Biotech Rna Pharmaceuticals Gmbh

Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz

11. 1 out of 17

Biontech Rna Pharmaceuticals Gmbh

12. 1 out of 15

Tron—translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz Ggmbh

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173046 - TNFR2 agonists with improved stability (2024-12-24),

2. 12065472 - Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity (2024-08-20),

3. 11142558 - Tumor necrosis factor receptor (TNFR) binding protein complex with improved binding and bioactivity (2021-10-12),

4. 11028178 - Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody (2021-06-08),

5. 10864278 - Antibody-drug conjugates and immunotoxins (2020-12-15),

6. 10808019 - Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands (2020-10-20),

7. 10689452 - Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof (2020-06-23),

8. 10570206 - Recombinant TNF ligand family member polypeptides with antibody binding domain and uses thereof (2020-02-25),

9. 10428149 - Single-chain tumor necrosis factor (TNF) ligand family molecules, fusion proteins and derivatives thereof (2019-10-01),

10. 10301368 - Cytokine fusion proteins (2019-05-28),

11. 10137202 - Antibody-drug conjugates and immunotoxins (2018-11-27),

12. 10004812 - Antibody-drug conjugates and immunotoxins (2018-06-26),

13. 9944708 - Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines) (2018-04-17),

14. 9822179 - Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor (2017-11-21),

15. 9045535 - huTNFR1 selective antagonists (2015-06-02),

Title: Klaus Pfizenmaier - Innovative Inventor from Tiefenbronn

Introduction: Klaus Pfizenmaier is a renowned inventor hailing from Tiefenbronn, Germany, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Klaus Pfizenmaier holds several patents in the areas of renewable energy, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Klaus Pfizenmaier has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized industries worldwide.

Collaborations: Throughout his career, Klaus Pfizenmaier has collaborated with top engineers, scientists, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Klaus Pfizenmaier's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and entrepreneurs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…